Related Experiment Video
Updated: Oct 16, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in
Giacomo Cafaro1, Carlo Perricone1, Ilenia Riccucci1
1Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.
Insights
Cardiovascular risk prediction in rheumatoid arthritis and Sjögren's syndrome patients is suboptimal with current algorithms. Disease activity and inflammatory markers are crucial for accurate risk assessment in these populations.
Area of Science:
- Rheumatology
- Cardiovascular Medicine
- Epidemiology
Background:
- Cardiovascular (CV) risk algorithms often underestimate risk in rheumatic diseases due to exclusion of disease-specific factors.
- Rheumatoid arthritis (RA) and Sjögren's syndrome (SS) patients have unique pathophysiological pathways contributing to CV disease.
- Accurate CV risk stratification is essential for managing these patient populations.
Purpose of the Study:
- To evaluate the performance of two established CV risk algorithms (Reynolds Risk Score and "Progetto Cuore") in RA and SS cohorts.
- To identify specific variables not included in these algorithms that significantly predict CV risk in RA and SS patients.
- To inform the development of more accurate CV risk assessment tools for individuals with rheumatic conditions.
Main Methods:
- A cohort of 77 RA patients and 68 SS patients without prior CV events was analyzed.
- Clinical, serological, and traditional CV risk factors were collected for all participants.
- Ten-year CV risk was calculated using the Reynolds Risk Score (RSS) and "Progetto Cuore" algorithms.
Main Results:
- The prevalence of traditional CV risk factors and predicted 10-year CV risk were comparable between RA and SS cohorts.
- In RA, body mass index (BMI) and disease activity predicted "Progetto Cuore" risk, while BMI and bone erosions predicted RSS.
- In SS, C-reactive protein predicted "Progetto Cuore" risk, whereas hypertension, ESSDAI, and LDL-cholesterol predicted RSS.
Conclusions:
- The 10-year risk for fatal and non-fatal CV events is similar in RA and SS patients.
- Traditional CV risk factors, such as hypertension, significantly influence CV risk in these rheumatic disease cohorts.
- Inflammatory parameters and disease activity are critical disease-specific variables that warrant inclusion in future CV risk assessment algorithms for rheumatic diseases.
Objectives:
Several cardiovascular (CV) risk algorithms are available to predict CV events in the general population. Their performance and validity in rheumatic disease patients is suboptimal as some disease-specific variables which strongly contribute to the pathogenesis of CV disease are not included in these CV algorithms. We aimed to evaluate the performance of two CV algorithms and investigate which variables not included in the score contribute to CV risk score in a cohort of rheumatoid arthritis (RA) and Sjögren's syndrome (SS) patients.
Methods:
A consecutive cohort of 77 RA and 68 SS patients without prior CV events was included. Clinical and serological features and traditional CV risk factors were collected. The 10-year CV risk was assessed by Reynold Risk Score (RSS) and "Progetto Cuore" algorithms.
Results:
Prevalence of traditional CV risk factors and 10-year risk of fatal and non-fatal CV events assessed by RSS and "Progetto Cuore" were similar between the two cohorts. Multiple linear regression model showed that, among variables not included in both algorithms, body mass index (BMI) and disease activity were predictors of "Progetto Cuore" while BMI and bone erosions of RSS in RA. In SS, C-reactive protein was predictor of "Progetto Cuore" while hypertension, ESSDAI and LDL-cholesterol of RSS.
Conclusions:
The 10-year risk of fatal and non-fatal CV events is similar in RA and SS. Traditional CV risk factors, as hypertension, strongly contribute to CV risk in these patients. Inflammatory parameters and disease activity are two disease-specific variables which should be included in CV algorithm assessment in rheumatic disease patients.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

